03:20 PM EDT, 08/16/2024 (MT Newswires) -- Serina Therapeutics ( SER ) appointed Gregory S. Curhan as its chief financial officer in a non-employee consultant role effective Friday, the company said in a Thursday regulatory filing with the US Securities and Exchange Commission.

Curhan is a partner at FLG Partners, the company said.

Serina Therapeutics ( SER ) shares were up 6.5% in recent trading.

Price: 7.17, Change: +0.51, Percent Change: +7.66